Core Viewpoint - Shanghai Zhaoxin Integrated Circuit Co., Ltd. has officially submitted its IPO application to the Sci-Tech Innovation Board, marking a significant step in its market expansion and technological development [1][2]. Company Overview - Zhaoxin Integrated focuses on the research, design, and sales of general-purpose processors (CPUs) and supporting chips, including desktop processors, server processors, and embedded processors [1]. - The company has established a fully autonomous design process and has developed its own instruction set, enabling it to innovate and evolve its CPU microarchitecture independently [1]. Market Position and Financial Performance - Zhaoxin has achieved a leading market position in the domestic desktop PC market, with its CPUs being the most widely used in products from major manufacturers like Lenovo and Inspur [2]. - The company reported revenues of 340 million yuan, 555 million yuan, and 889 million yuan for the years 2022, 2023, and 2024 respectively, reflecting a compound annual growth rate of 61.71% [2]. Breakthroughs in Medical Sector - Zhaoxin has made significant inroads in the medical sector, winning a bid for over 6,000 medical desktop PCs against major competitors Intel and AMD, indicating the growing competitiveness of domestic CPUs [2]. - The company’s processors support the latest x86 instruction sets and have successfully developed and mass-produced six generations of high-performance general-purpose processors [3]. Ecosystem and Collaboration - Zhaoxin has established a wide ecosystem with nearly 4,000 partners in system integration, software, and hardware, collaborating with major domestic operating system vendors to complete over 200,000 software and hardware adaptation projects [4]. - The company provides comprehensive support for medical institutions, ensuring the stable operation of critical applications like electronic medical records and telemedicine platforms, while also protecting patient privacy data [4].